Arcturus Therapeutics Holdings Inc (ARCT)
18.30
+0.48
(+2.69%)
USD |
NASDAQ |
Nov 05, 16:00
18.30
0.00 (0.00%)
After-Hours: 18:56
Arcturus Therapeutics Holdings Cash from Operations (Quarterly): -30.14M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -30.14M |
| March 31, 2024 | -5.557M |
| December 31, 2023 | -0.629M |
| September 30, 2023 | -32.41M |
| June 30, 2023 | 50.81M |
| March 31, 2023 | -35.87M |
| December 31, 2022 | 160.26M |
| September 30, 2022 | -42.41M |
| June 30, 2022 | -36.82M |
| March 31, 2022 | -49.04M |
| December 31, 2021 | -42.50M |
| September 30, 2021 | -16.65M |
| June 30, 2021 | -32.94M |
| March 31, 2021 | -42.95M |
| December 31, 2020 | -6.632M |
| September 30, 2020 | -15.88M |
| June 30, 2020 | -8.494M |
| March 31, 2020 | -11.86M |
| December 31, 2019 | -7.538M |
| September 30, 2019 | -2.836M |
| June 30, 2019 | 9.34M |
| March 31, 2019 | -5.411M |
| December 31, 2018 | -5.763M |
| Date | Value |
|---|---|
| September 30, 2018 | -6.795M |
| June 30, 2018 | -7.841M |
| March 31, 2018 | -0.361M |
| December 31, 2017 | 5.001M |
| September 30, 2017 | -1.73M |
| June 30, 2017 | 1.233M |
| March 31, 2017 | -4.964M |
| December 31, 2016 | 12.36M |
| September 30, 2016 | -6.675M |
| June 30, 2016 | -4.106M |
| March 31, 2016 | -4.437M |
| December 31, 2015 | 22.16M |
| September 30, 2015 | -5.383M |
| June 30, 2015 | -3.891M |
| March 31, 2015 | -4.595M |
| December 31, 2014 | -7.741M |
| September 30, 2014 | -9.489M |
| June 30, 2014 | -5.468M |
| March 31, 2014 | -5.628M |
| December 31, 2013 | -4.829M |
| September 30, 2013 | -1.988M |
| June 30, 2013 | -0.355M |
| March 31, 2013 | -0.181M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-49.04M
Minimum
Mar 2022
160.26M
Maximum
Dec 2022
-10.91M
Average
-16.65M
Median
Sep 2021
Cash from Operations (Quarterly) Benchmarks
| Fulcrum Therapeutics Inc | 58.90M |
| Bioventus Inc | 15.16M |
| Semler Scientific Inc | 4.934M |
| Liquidia Corp | -22.66M |
| Pfizer Inc | -1.781B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.328M |
| Cash from Financing (Quarterly) | 2.403M |
| Free Cash Flow | -71.16M |
| Free Cash Flow Per Share (Quarterly) | -1.130 |
| Free Cash Flow to Equity (Quarterly) | -30.47M |
| Free Cash Flow to Firm (Quarterly) | -30.47M |
| Free Cash Flow Yield | -14.50% |